Rsc Drug Discovery

Nanostructured Biomaterials for Overcoming Biological Barriers: RSC (RSC Drug Discovery)

Nanostructured Biomaterials for Overcoming Biological Barriers: RSC (RSC Drug Discovery) by Maria Jose Alonso
Royal Society of Chemistry | July 30, 2012 | English | ISBN: 1849733635 | 644 pages | PDF | 173 MB

This book provides a critical overview of the advances being made towards overcoming biological barriers through the contribution of nanosciences and nanotechnologies.
G Protein-Coupled Receptors: From Structure to Function (RSC Drug Discovery)

Jesus Giraldo, "G Protein-Coupled Receptors: From Structure to Function (RSC Drug Discovery)"
ISBN: 1849731837 | 2011 | PDF | 512 pages | 16.6 MB
Drug Design Strategies: Quantitative Approaches (RSC Drug Discovery)

David J Livingstone, "Drug Design Strategies: Quantitative Approaches (RSC Drug Discovery)"
Publisher: R**l So**ty of Chemistry | ISBN: 1849731667 | 2012 | PDF | 517 pages | 6 MB

Green Chemistry Strategies for Drug Discovery  

Posted by interes at July 27, 2015
Green Chemistry Strategies for Drug Discovery

Green Chemistry Strategies for Drug Discovery (RSC Drug Discovery) by Emily A. Peterson and Julie B. Manley
English | 2015 | ISBN: 1849739617 | 347 pages | PDF | 8,5 MB

Drug Discovery for Schizophrenia  

Posted by interes at May 4, 2015
Drug Discovery for Schizophrenia

Drug Discovery for Schizophrenia (RSC Drug Discovery) by Tatiana V Lipina and John C Roder
English | 2015 | ISBN: 1782620265 | 286 pages | PDF | 4 MB

Polyamine Drug Discovery  eBooks & eLearning

Posted by MoneyRich at Nov. 24, 2016
Polyamine Drug Discovery

Polyamine Drug Discovery by RSC Publishing
English | 11 Jan. 2011 | ISBN: 184973190X | 302 Pages | PDF | 8 MB

Polyamines are ubiquitous molecules that are involved in a number of important cellular processes. Aberrations in their function or metabolism play a role in diseases such as cancer and parasitic infection. A number of validated drug targets have been identified, including enzymes in the polyamine biosynthetic and catabolic pathways and the S-adenosylmethionine synthetic and salvage pathways.
Biochips as Pathways to Drug Discovery (Drug Discovery Series) by Gary Hardiman

Biochips as Pathways to Drug Discovery (Drug Discovery Series) by Gary Hardiman
English | Oct 19, 2006 | ISBN: 1574444506 | 420 Pages | PDF | 14 MB

In the fiercely competitive pharmaceutical marketplace, your organization cannot afford to spend excess dollars developing drugs that will fail to get FDA approval or have profoundly poor characteristics.
Accounts in Drug Discovery: Case Studies in Medicinal Chemistry

Accounts in Drug Discovery: Case Studies in Medicinal Chemistry By RSC Publishing
2010 | 370 Pages | ISBN: 1849731268 | PDF | 10 MB
Exploiting Chemical Diversity for Drug Discovery: RSC (RSC Biomolecular Sciences) by Paul A Bartlett

Exploiting Chemical Diversity for Drug Discovery: RSC (RSC Biomolecular Sciences) by Paul A Bartlett
English | Apr 7, 2006 | ISBN: 0854048421 | 442 Pages | PDF | 7 MB

Conceptual and technological advances in chemistry and biology have transformed the drug discovery process. Evolutionary pressure among the diverse scientific and engineering disciplines that contribute to the identification of biologically active compounds has resulted in synergistic improvements at every step in the process.

Animal Models for Neurodegenerative Disease: RSC  

Posted by MoneyRich at Jan. 28, 2015
Animal Models for Neurodegenerative Disease: RSC

Animal Models for Neurodegenerative Disease: RSC (RSC Drug Discovery) by Jesus Avila
English | May 24, 2011 | ISBN: 1849731845 | 306 Pages | PDF | 3 MB

In recent years, medical developments have resulted in an increase in human life expectancy. Some developed countries now have a larger population of individuals aged over 64 than those under 14. One consequence of the ageing population is a higher incidence of certain neurodegenerative disorders. In order to prevent these, we need to learn more about them. This book provides up-to-date information on the use of transgenic mouse models in the study of neurodegenerative disorders such as Alzheimer's and Huntington's disease.